Low event rates and short TTRs with warfarin were notable, and questions persist as to which patients truly need OAC.

A week later she developed a pulmonary embolism, due to a deep vein thrombosis and was treated with warfarin (5 mg/d) (heparin therapy was simultaneously discontinued). The patient was ...

[55] The INR of a 47- year-old man who had been receiving warfarin for nine months (7.5 mg every Tuesday and 5 mg on all other days) to prevent thrombotic complications associated with a ...

Patients who receive a heart valve replacement are well-known to be at a high risk for stroke, blood clots and deep vein ...

Edoxaban, an oral anticoagulant, was equally or more effective than warfarin in reducing the risk of stroke and blood clots for patients after heart valve replacement surgery, according to preliminary ...

Edoxaban, a medication taken orally to prevent blood clots from forming, was found to be as effective and safe for stroke and ...

The FDA informed Intercept that it is unable to approve the sNDA in its current form, consistent with the outcome of the Gastrointestinal Drugs Advisory Committee (GIDAC) meeting in September 2024. In ...

Edoxaban (Savaysa) appeared at least on par with warfarin for 12-week thromboembolic prophylaxis after bioprosthetic valve ...

At the moment, the company is developing novel therapeutic approaches for patients with underserved heart issues, such as ...

Advances in cardiac imaging techniques and risk categorization have led to improvements in diagnosis, initial treatment and ...

Advances in cardiac imaging techniques and risk categorization have led to improvements in diagnosis, initial treatment and ...